Literature DB >> 1627600

Molecular expression of the negative growth factor murine beta-galactoside binding protein (mGBP).

V Wells1, L Mallucci.   

Abstract

Characterisation of the negative growth factor mGBP at molecular and biological levels indicates that the protein has no lectin nature and suggests instead a participation in the cytokine network. The protein is shown to be expressed as a monomer in two forms, one of which is non-covalently linked to a glycan complex. This confers greater efficiency to the inhibitor and may favour a paracrine role. The two monomeric forms may oxidise into tetramers which retain biological activity, but lack ability to link to specific saccharide residues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627600     DOI: 10.1016/0167-4838(92)90152-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Dermal fibroblasts participate in the formation of new muscle fibres when implanted into regenerating normal mouse muscle.

Authors:  D Pye; D J Watt
Journal:  J Anat       Date:  2001-02       Impact factor: 2.610

Review 2.  The involvement of galectin-1 in skeletal muscle determination, differentiation and regeneration.

Authors:  Diana J Watt; Gareth E Jones; Kirstin Goldring
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

3.  Expression of the 14 kDa and 16 kDa galactoside-binding lectins during differentiation of the chick yolk sac.

Authors:  Christopher K Guay; Sara E Zalik
Journal:  Rouxs Arch Dev Biol       Date:  1994-12

4.  Galectins in hematological malignancies.

Authors:  Yves St-Pierre
Journal:  Am J Blood Res       Date:  2011-09-07

Review 5.  Galectin-1: a bifunctional regulator of cellular proliferation.

Authors:  Ken Scott; Cristina Weinberg
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 6.  Galectin-1 plays essential roles in adult mammalian nervous tissues. Roles of oxidized galectin-1.

Authors:  Hidenori Horie; Toshihiko Kadoya
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

7.  Tregs utilize beta-galactoside-binding protein to transiently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferation.

Authors:  Dolgor Baatar; Purevdorj B Olkhanud; Valerie Wells; Fred E Indig; Livio Mallucci; Arya Biragyn
Journal:  Brain Behav Immun       Date:  2009-06-09       Impact factor: 7.217

8.  Partial identification by site-directed mutagenesis of a cell growth inhibitory site on the human galectin-1 molecule.

Authors:  Ken Scott; Jialiang Zhang
Journal:  BMC Cell Biol       Date:  2002-01-25       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.